申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20180214445A1
公开(公告)日:2018-08-02
Disclosed is a compound of Formula (I) or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate or prodrug thereof, wherein one R
3
is H and the other R
3
is an aryl group substituted with zero to 3 R
3a
; and R
1
, R
2
, and R
3a
are defined herein. Also disclosed are methods of using such compounds as PAR4 inhibitors for the inhibition or prevention of platelet aggregation, and the treatment of a thromboembolic disorder or the primary prophylaxis of a thromboembolic disorder. Also disclosed are methods of using such compounds for the treatment of human papillomavirus. Additionally, pharmaceutical compositions comprising at least one compound of Formula (I) are disclosed.